LCN2 and Alzheimer disease: In AD cases (stages V and VI), LCN2 immunoreactivity was preserved in capillaries but increased in a subpopulation of astrocytes localized around β-amyloid plaques or layered in the cerebral cortex, and in reactive microglia (Fig. 4a, upper-right).